Bank Julius Baer & Co. Ltd Zurich Sells 36,459 Shares of The Cigna Group (NYSE:CI)

Bank Julius Baer & Co. Ltd Zurich cut its holdings in shares of The Cigna Group (NYSE:CI) by 90.3% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 3,926 shares of the health services provider’s stock after selling 36,459 shares during the quarter. Bank Julius Baer & Co. Ltd Zurich’s holdings in The Cigna Group were worth $1,176,000 as of its most recent SEC filing.

Several other hedge funds also recently made changes to their positions in CI. Roman Butler Fullerton & Co. increased its stake in The Cigna Group by 61.4% in the fourth quarter. Roman Butler Fullerton & Co. now owns 9,307 shares of the health services provider’s stock valued at $2,772,000 after acquiring an additional 3,539 shares during the last quarter. Ellsworth Advisors LLC bought a new position in The Cigna Group in the fourth quarter valued at approximately $4,377,000. Sapient Capital LLC bought a new position in The Cigna Group in the fourth quarter valued at approximately $2,811,000. Allspring Global Investments Holdings LLC grew its stake in shares of The Cigna Group by 29.5% during the fourth quarter. Allspring Global Investments Holdings LLC now owns 293,438 shares of the health services provider’s stock worth $87,870,000 after buying an additional 66,891 shares during the last quarter. Finally, Accurate Wealth Management LLC bought a new stake in shares of The Cigna Group during the fourth quarter worth $2,244,000. 86.99% of the stock is owned by institutional investors.

Insider Buying and Selling at The Cigna Group

In other The Cigna Group news, SVP Hoeltzel Mary T. Agoglia sold 4,867 shares of The Cigna Group stock in a transaction on Wednesday, February 7th. The shares were sold at an average price of $330.48, for a total value of $1,608,446.16. Following the completion of the sale, the senior vice president now directly owns 2,102 shares of the company’s stock, valued at $694,668.96. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. In other news, SVP Hoeltzel Mary T. Agoglia sold 4,867 shares of the business’s stock in a transaction dated Wednesday, February 7th. The shares were sold at an average price of $330.48, for a total transaction of $1,608,446.16. Following the completion of the sale, the senior vice president now directly owns 2,102 shares of the company’s stock, valued at $694,668.96. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CEO David Cordani sold 38,065 shares of the business’s stock in a transaction dated Friday, February 9th. The stock was sold at an average price of $335.22, for a total transaction of $12,760,149.30. Following the sale, the chief executive officer now directly owns 329,321 shares of the company’s stock, valued at $110,394,985.62. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 114,144 shares of company stock valued at $39,296,330. Corporate insiders own 0.60% of the company’s stock.

The Cigna Group Price Performance

CI stock opened at $354.41 on Friday. The firm has a market cap of $103.62 billion, a price-to-earnings ratio of 20.38, a PEG ratio of 1.09 and a beta of 0.56. The company has a quick ratio of 0.67, a current ratio of 0.67 and a debt-to-equity ratio of 0.61. The Cigna Group has a 12-month low of $240.50 and a 12-month high of $365.71. The company’s fifty day simple moving average is $349.88 and its 200 day simple moving average is $317.80.

The Cigna Group (NYSE:CI) last posted its quarterly earnings results on Friday, February 2nd. The health services provider reported $6.79 earnings per share for the quarter, beating the consensus estimate of $6.54 by $0.25. The Cigna Group had a net margin of 2.64% and a return on equity of 13.59%. The firm had revenue of $51.15 billion during the quarter, compared to the consensus estimate of $48.91 billion. During the same period in the previous year, the firm posted $4.96 earnings per share. The business’s revenue was up 11.8% compared to the same quarter last year. On average, analysts expect that The Cigna Group will post 28.36 earnings per share for the current year.

The Cigna Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, June 20th. Shareholders of record on Tuesday, June 4th will be paid a $1.40 dividend. This represents a $5.60 annualized dividend and a yield of 1.58%. The ex-dividend date is Tuesday, June 4th. The Cigna Group’s dividend payout ratio (DPR) is currently 32.20%.

Analyst Ratings Changes

A number of research firms have weighed in on CI. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $384.00 target price on shares of The Cigna Group in a research note on Wednesday, April 10th. Morgan Stanley reiterated an “overweight” rating and set a $392.00 price target (up previously from $382.00) on shares of The Cigna Group in a report on Monday, March 4th. Sanford C. Bernstein upgraded shares of The Cigna Group from a “market perform” rating to an “outperform” rating and lifted their price target for the stock from $330.00 to $372.00 in a report on Thursday, January 4th. Royal Bank of Canada upgraded shares of The Cigna Group from a “sector perform” rating to an “outperform” rating and lifted their price target for the stock from $327.00 to $354.00 in a report on Monday, February 5th. Finally, Wells Fargo & Company lifted their price target on shares of The Cigna Group from $334.00 to $348.00 and gave the stock an “equal weight” rating in a report on Tuesday, February 6th. Two research analysts have rated the stock with a hold rating, ten have assigned a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, the company has an average rating of “Buy” and an average price target of $362.14.

The Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.